Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Additionally, brand-name manufacturers invest heavily in research, development, and pharmacovigilance that compounders do not perform
Of course, Novo is not alone in its expansive R&D focus around obesity-related diseases
According to the FDA Prescribing Information for Wegovy (semaglutide 2.4 mg for weight management), headache was reported in 14.2% of patients receiving the medication compared to 10.0% in the placebo group in the STEP 1 trial
Doctors frequently prescribe it to treat obesity and health problems linked to it, like cardiovascular disease and obstructive sleep apnea
US$ 24.79
US$ 27.02
US$ 26.52
US$ 22.30
US$ 21.23
US$ 22.71
US$ 22.47
